What is the recommended management for a non‑bleeding, oozing gastric ulcer?

Management of Non-Bleeding Oozing Gastric Ulcer

For a non-bleeding, oozing gastric ulcer (Forrest Ib), you should perform endoscopic hemostatic therapy immediately using combination therapy: epinephrine injection plus a second modality such as bipolar electrocoagulation, heater probe, or through-the-scope clips. 1

Endoscopic Management Algorithm

Immediate Endoscopic Therapy Required

An oozing ulcer represents Forrest Ib classification and is considered a high-risk stigmata requiring immediate endoscopic intervention 1. The term "non-bleeding" in your question appears contradictory since "oozing" itself represents active bleeding, albeit slower than spurting.

Recommended endoscopic approaches:

• Combination therapy (preferred): Epinephrine injection PLUS a second modality 1

  • Epinephrine injection alone is suboptimal and should never be used as monotherapy 1
  • Second modality options include:
    • Bipolar electrocoagulation (strong recommendation) 1
    • Heater probe (strong recommendation) 1
    • Through-the-scope clips (conditional recommendation) 1
    • Sclerosant injection 1

• Alternative first-line options:

  • Over-the-scope (OTS) clips as monotherapy may be used as an alternative to combination therapy, with lower rebleeding risk 2
  • Hemostatic forceps with soft coagulation as monotherapy 2

Post-Endoscopic Pharmacologic Management

After successful endoscopic hemostasis, initiate high-dose PPI therapy 1:

1. Intravenous PPI regimen (preferred for first 72 hours):

   • 80 mg IV bolus followed by 8 mg/hour continuous infusion for 72 hours 1
   • This is a strong recommendation with moderate-to-high quality evidence 1

2. Transition to oral PPI:

   • After 72 hours of IV therapy, switch to twice-daily oral PPI for 14 days 1
   • Then continue once-daily PPI as dictated by underlying cause 1

Hospitalization and Monitoring

• Hospitalize for at least 72 hours after endoscopic hemostasis for high-risk stigmata 1
• Monitor for signs of rebleeding (hemodynamic instability, hematemesis, melena)
• Early oral nutrition can be initiated within 24 hours if durable hemostasis achieved 2

Management of Rebleeding

If rebleeding occurs after initial successful hemostasis:

1. Second endoscopic attempt with consideration of OTS clips 2, 3
2. If second endoscopy fails: Transcatheter angiographic embolization (TAE) should be performed 2, 3
3. Surgery indicated only when TAE unavailable or unsuccessful 2, 3

Addressing Underlying Etiology

Test for H. pylori

• Perform testing in acute setting 1, 4
• If positive, initiate eradication therapy 1, 4
• Retest if initially negative (acute setting tests can be falsely negative) 1, 4
• Document successful eradication 1, 4

NSAID/Aspirin Management

• If on low-dose aspirin for secondary cardiovascular prophylaxis: Resume aspirin within 3-5 days once hemostasis established 5, 3
• If on NSAIDs: Discontinue if possible; if must continue, use COX-2 selective NSAID plus PPI 1

Common Pitfalls to Avoid

1. Never use epinephrine injection alone - this is explicitly contraindicated as monotherapy 1
2. Do not perform routine second-look endoscopy - only repeat if clinical evidence of rebleeding 1
3. Do not delay endoscopy for PPI administration - while pre-endoscopic PPI may be given, it should not postpone early endoscopy 1
4. Do not discharge early - patients with high-risk stigmata requiring endoscopic therapy need 72-hour observation 1